Select Page

Avgeris Margaritis

Scientific Collaborator

N/A

N/A

School of Sciences

Department of Life Sciences

Academic Qualifications

Qualification Year Awarding Institution Department
Bachelor of Science (BSc) 2004 National and Kapodistrian University of Athens (NKUA) Faculty of Biology
Master of Science (MSc) 2007 National and Kapodistrian University of Athens (NKUA) Faculties of Biology, Chemistry, Medicine and Nursing
Doctor of Philosophy (PhD) 2016 National and Kapodistrian University of Athens (NKUA) Faculty of Biology

Employment History

Period of employment Employer Location Position
From To
2019 Today National and Kapodistrian University of Athens (NKUA) Athens, Greece Assoc. Professor, School of Medicine
2018 2019 National and Kapodistrian University of Athens (NKUA) Athens, Greece Academic Fellow, Post-Doctoral Researcher, Faculty of Biology
2017 2018 National and Kapodistrian University of Athens (NKUA) Athens, Greece Academic Fellow, Post-Doctoral Researcher, Faculty of Biology

Publications

Year Title Other authors Journal and Publisher / Conference Vol. Pages
2020 tRNA‐derived fragments (tRFs) in bladder cancer: Increased 5’-tRF-LysCTT results in disease early-progression and patients’ poor treatment outcome Papadimitriou MA, Avgeris M, Levis P, Papasotiriou EC, Kotronopoulos G, Stravodimos K, Scorilas A Cancers   3661
2020 Analytical methodologies for the detection of SARS-CoV-2 in wastewater: Protocols and future perspectives Alygizakis N, Markou AN, Rousis NI, Galani A, Avgeris M, Adamopoulos PG, Scorilas A, Lianidou ES, Paraskevis D, Tsiodras S, Tsakris A, Dimopoulos MA, Thomaidis NS Trends in Analytical Chemistry   116125
2020 miR-181a overexpression predicts the poor treatment response and early-progression of serous ovarian cancer patients   Panoutsopoulou K, Avgeris M, Mavridis K, Dreyer T, Dorn J, Obermayr E, Reinthaller A, Michaelidou K, Mahner S, Vergote I, Loverix L, Braicu I, Sehouli J, Zeillinger R, Magdolen V, Scorilas A International Journal of Cancer   3560-3573
2020 Circulating miR-146a and miR-134 in predicting drug resistant focal impaired awareness epilepsy Leontariti M, Avgeris M, Katsarou MS, Drakoulis N, Siatouni A, Verentzioti A, Alexoudi A, Fytraki A, Patrikelis P, Vassilacopoulou D, Gatzonis S, Sideris DC Epilepsia   959-970
2020 Blood-based analysis of 84 microRNAs identifies specific molecules with deregulated expression in patients and individuals at risk for type-2 diabetes Avgeris M, Kokkinopoulou I, Maratou E, Mitrou P, Boutati E, Scorilas A, Fragoulis EG, Christodoulou MI Diabetes Research and Clinical Practice   108187
2014 A new tumor suppressor role for the Notch pathway in bladder cancer Rampias T, Vgenopoulou P, Avgeris M, Polyzos A, Stravodimos K, Valavanis C, Scorilas A, Klinakis A Nature Medicine   1199-205
2013 The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients Avgeris M, Stravodimos K, Fragoulis EG., Scorilas A British Journal of Cancer   2573-81
2016 Evaluation of PD-L1 expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Vassilakopoulou M*, Avgeris M*, Velcheti V, Kotoula V, Rampias T, Chatzopoulos K, Perisanidis C, Kontos CK, Giotakis AI, Scorilas A, Rimm L, Sasaki CT, Fountzilas G, Psyrri A (*Equal contribution)   Clinical Cancer Research   704-13
2019 The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer Rampias T, Karagiannis D, Avgeris M, Polyzos A, Kokkalis A, Kanaki Z, Kousidou E , Tzetis M, Kanavakis E, Stravodimos K, Manola KN, Pantelias GE, Scorilas A, Klinakis A EMBO Reports   e46821
2018 Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients Avgeris M, Tsilimantou A, Levis PK, Tokas T, Sideris DC, Stravodimos K, Ardavanis A, Scorilas A British Journal of Cancer   1477-1486

Exhibitions

Research Projects

Date Title Funded by Project Role*
2020-2023 Non-invasive molecular method for diagnosis and personalized post-treatment monitoring of bladder cancer RESEARCH - CREATE – INNOVATE, 2014-2020 Research Team Member
2013-2015 Exploiting developments in bioinformatics and emerging microarrays technology for building a new generation of health care system, with a view to efficient management, prevention and individualized medicine treatment of Diabetes Mellitus type 2 SYNERGASIA, 2013-2015 Research Team Member
2013-2014 The role of Notch in the development of urothelial cancer ARISTIA, 2013-2014 Research Team Member
2013-2015 Identification and Evaluation of Novel BIOmarkers for Early Diagnosis, PROgnosis, and Treatment MOnitoring of Breast and Prostate Cancers, through the Development of Hypersensitive Molecular Methodologies (BIOPROMO) THALIS, 2011-2015 Research Team Member

Academic Consulting Services/Councils/Boards/Editorial Committees

Awards/International Recognition

Date Title Awarded by:
2014 Poster award for the: Avgeris M., Tokas T., Stravodimos K., Fragoulis E.G., Scorilas A. Uncovering the dual clinical value of miR-143/145 cluster in bladder cancer epithelium and patients survival outcome Federation of European Biochemical Societies (FEBS)
2012 «Distinguished Abstracts Award» for the poster: Avgeris M., Stravodimos K., Fragoulis E. G., Scorilas A. miR-145 And Its Target, L-Dopa Decarboxylase (DDC), Are Promising Prognostic Biomarkers For The Disease-Free Survival of Prostate Cancer Patients National Academy of Clinical Biochemistry (NACB) of USA
2011 Poster award for the: Avgeris M., Stravodimos K., Fragoulis E.G.,Scorilas A. L-dopa decarboxylase (DDC) gene overexpression contributes significantly in prostate cancer patients' prognosis. Federation of European Biochemical Societies (FEBS)
2016 Oral presentation award for the: Avgeris M., Scorilas A. Non-coding RNAs as novel biomarkers in urological cancers International Society for Enzymology (ISE)

Other Achievements